Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Dotson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
Specialty pharmacy for hematologic malignanciesSusan Fajardo, Felicia Zook, Emily Dotson
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2015
Sixty-minute infusion rituximab protocol allows for safe and efficient workflowEmily Dotson, Brooke Crawford, Gary Phillips, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 9, 2015
Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicityTracy Wiczer, Emily Dotson, Amy Tuten, et al.
Proceedings of the American Thoracic Society|May 14, 2010
Traditional and emerging antifungal therapiesTamra M Arnold, Emily Dotson, George A Sarosi, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2018
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin LymphomaDavid A Bond, Emily Dotson, Farrukh T Awan, et al.
Leukemia & Lymphoma|December 14, 2023
Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomasZachary Braunstein, Allyson Waller, Emily Dotson, et al.
British Journal of Haematology|July 21, 2018
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centreKerry A Rogers, Ying Huang, Emily Dotson, et al.
Therapeutic Advances in Hematology|July 28, 2022
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective studyMegan Fleming, Ying Huang, Emily Dotson, et al.
Blood Advances|November 17, 2021
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomasMegan Fleming, Ying Huang, Emily Dotson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 13, 2026
Oncology pharmacist survey: Understanding task value and professional satisfactionLydia L Benitez, Jessie Signorelli, Kristin Adler, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
Specialty pharmacy for hematologic malignanciesSusan Fajardo, Felicia Zook, Emily Dotson
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2015
Sixty-minute infusion rituximab protocol allows for safe and efficient workflowEmily Dotson, Brooke Crawford, Gary Phillips, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 9, 2015
Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicityTracy Wiczer, Emily Dotson, Amy Tuten, et al.
Proceedings of the American Thoracic Society|May 14, 2010
Traditional and emerging antifungal therapiesTamra M Arnold, Emily Dotson, George A Sarosi, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2018
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin LymphomaDavid A Bond, Emily Dotson, Farrukh T Awan, et al.
Leukemia & Lymphoma|December 14, 2023
Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomasZachary Braunstein, Allyson Waller, Emily Dotson, et al.
British Journal of Haematology|July 21, 2018
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centreKerry A Rogers, Ying Huang, Emily Dotson, et al.
Therapeutic Advances in Hematology|July 28, 2022
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective studyMegan Fleming, Ying Huang, Emily Dotson, et al.
Blood Advances|November 17, 2021
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomasMegan Fleming, Ying Huang, Emily Dotson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 13, 2026
Oncology pharmacist survey: Understanding task value and professional satisfactionLydia L Benitez, Jessie Signorelli, Kristin Adler, et al.
Pageof 2